Loading…
Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors
Background The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survi...
Saved in:
Published in: | Thoracic cancer 2021-12, Vol.12 (23), p.3110-3120 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73 |
---|---|
cites | cdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73 |
container_end_page | 3120 |
container_issue | 23 |
container_start_page | 3110 |
container_title | Thoracic cancer |
container_volume | 12 |
creator | Zhu, Chao Ding, Jialin Wang, Songping Qiu, Qingtao Ji, Youxin Wang, Linlin |
description | Background
The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF.
Methods
The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation.
Results
For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones.
Conclusions
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas.
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions f |
doi_str_mv | 10.1111/1759-7714.14115 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d55ac551265e49c2a72b7580f2061d4d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d55ac551265e49c2a72b7580f2061d4d</doaj_id><sourcerecordid>2604953177</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</originalsourceid><addsrcrecordid>eNqFkctr3DAQxk1paUKac29F0PMmkvWyL4WwfQUCvaRnMXo5WmzLlbxbAvnjK6_TpTl1LpJG3_w0o6-q3hN8RUpcE8nbjZSEXRFGCH9VnZ8yr097LM6qy5x3uARtWlzzt9UZZYJJRuR59fTZHVwfp8GNM4LRogP0wcIc4oiiR4CmFLsx5jkYNMYhdgkG5GNCQ9F1I5Qql-P0AJ2DHvmQ530PSEN2FhVEAhviEEw-sk0fxmAWHZg5pvyueuOhz-7yeb2ofn79cr_9vrn78e12e3O3MZxSvuGYad0ITi1w7bltiNSsDOZxQ3RLLG1FQxrXSAMSLNNe43IkFvu6dcJKelHdrlwbYaemFAZIjypCUMdETJ2CVCbsnbKcg-Gc1II71poaZK0lbwoKC2KZLaxPK2va68FZU_4tQf8C-vJmDA-qiwfVCCpqggvg4zMgxV97l2e1i_s0lvlVLTBrOSVyafl6VZkUc07On14gWC3uq8VftXitju6Xig__NnbS__W6CPgq-B169_g_nrrf3qzgP4l4u00</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2604953177</pqid></control><display><type>article</type><title>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</title><source>Open Access: Wiley-Blackwell Open Access Journals</source><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Zhu, Chao ; Ding, Jialin ; Wang, Songping ; Qiu, Qingtao ; Ji, Youxin ; Wang, Linlin</creator><creatorcontrib>Zhu, Chao ; Ding, Jialin ; Wang, Songping ; Qiu, Qingtao ; Ji, Youxin ; Wang, Linlin</creatorcontrib><description>Background
The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF.
Methods
The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation.
Results
For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones.
Conclusions
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas.
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistula.</description><identifier>ISSN: 1759-7706</identifier><identifier>EISSN: 1759-7714</identifier><identifier>DOI: 10.1111/1759-7714.14115</identifier><identifier>PMID: 34647417</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Aged ; Body mass index ; Cancer therapies ; Chemotherapy ; Disease-Free Survival ; Esophageal cancer ; esophageal fistula ; Esophageal Fistula - diagnostic imaging ; Esophageal Fistula - pathology ; Esophageal Neoplasms - diagnostic imaging ; Esophageal Neoplasms - pathology ; Female ; Fistula ; Humans ; Male ; Medical prognosis ; Medical records ; Middle Aged ; Neutrophils ; Nomograms ; Open source software ; Original ; Patients ; Prognosis ; prognostic factors ; Proportional Hazards Models ; Radiomics ; Retrospective Studies ; Risk Factors ; Statistical analysis ; Survival analysis ; Tomography, X-Ray Computed ; Tumors</subject><ispartof>Thoracic cancer, 2021-12, Vol.12 (23), p.3110-3120</ispartof><rights>2021 The Authors. published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.</rights><rights>2021 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd.</rights><rights>2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</citedby><cites>FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</cites><orcidid>0000-0001-7879-7281</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2604953177/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2604953177?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34647417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhu, Chao</creatorcontrib><creatorcontrib>Ding, Jialin</creatorcontrib><creatorcontrib>Wang, Songping</creatorcontrib><creatorcontrib>Qiu, Qingtao</creatorcontrib><creatorcontrib>Ji, Youxin</creatorcontrib><creatorcontrib>Wang, Linlin</creatorcontrib><title>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</title><title>Thoracic cancer</title><addtitle>Thorac Cancer</addtitle><description>Background
The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF.
Methods
The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation.
Results
For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones.
Conclusions
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas.
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistula.</description><subject>Aged</subject><subject>Body mass index</subject><subject>Cancer therapies</subject><subject>Chemotherapy</subject><subject>Disease-Free Survival</subject><subject>Esophageal cancer</subject><subject>esophageal fistula</subject><subject>Esophageal Fistula - diagnostic imaging</subject><subject>Esophageal Fistula - pathology</subject><subject>Esophageal Neoplasms - diagnostic imaging</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Female</subject><subject>Fistula</subject><subject>Humans</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Medical records</subject><subject>Middle Aged</subject><subject>Neutrophils</subject><subject>Nomograms</subject><subject>Open source software</subject><subject>Original</subject><subject>Patients</subject><subject>Prognosis</subject><subject>prognostic factors</subject><subject>Proportional Hazards Models</subject><subject>Radiomics</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Statistical analysis</subject><subject>Survival analysis</subject><subject>Tomography, X-Ray Computed</subject><subject>Tumors</subject><issn>1759-7706</issn><issn>1759-7714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqFkctr3DAQxk1paUKac29F0PMmkvWyL4WwfQUCvaRnMXo5WmzLlbxbAvnjK6_TpTl1LpJG3_w0o6-q3hN8RUpcE8nbjZSEXRFGCH9VnZ8yr097LM6qy5x3uARtWlzzt9UZZYJJRuR59fTZHVwfp8GNM4LRogP0wcIc4oiiR4CmFLsx5jkYNMYhdgkG5GNCQ9F1I5Qql-P0AJ2DHvmQ530PSEN2FhVEAhviEEw-sk0fxmAWHZg5pvyueuOhz-7yeb2ofn79cr_9vrn78e12e3O3MZxSvuGYad0ITi1w7bltiNSsDOZxQ3RLLG1FQxrXSAMSLNNe43IkFvu6dcJKelHdrlwbYaemFAZIjypCUMdETJ2CVCbsnbKcg-Gc1II71poaZK0lbwoKC2KZLaxPK2va68FZU_4tQf8C-vJmDA-qiwfVCCpqggvg4zMgxV97l2e1i_s0lvlVLTBrOSVyafl6VZkUc07On14gWC3uq8VftXitju6Xig__NnbS__W6CPgq-B169_g_nrrf3qzgP4l4u00</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Zhu, Chao</creator><creator>Ding, Jialin</creator><creator>Wang, Songping</creator><creator>Qiu, Qingtao</creator><creator>Ji, Youxin</creator><creator>Wang, Linlin</creator><general>John Wiley & Sons Australia, Ltd</general><general>John Wiley & Sons, Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7879-7281</orcidid></search><sort><creationdate>202112</creationdate><title>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</title><author>Zhu, Chao ; Ding, Jialin ; Wang, Songping ; Qiu, Qingtao ; Ji, Youxin ; Wang, Linlin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Body mass index</topic><topic>Cancer therapies</topic><topic>Chemotherapy</topic><topic>Disease-Free Survival</topic><topic>Esophageal cancer</topic><topic>esophageal fistula</topic><topic>Esophageal Fistula - diagnostic imaging</topic><topic>Esophageal Fistula - pathology</topic><topic>Esophageal Neoplasms - diagnostic imaging</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Female</topic><topic>Fistula</topic><topic>Humans</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Medical records</topic><topic>Middle Aged</topic><topic>Neutrophils</topic><topic>Nomograms</topic><topic>Open source software</topic><topic>Original</topic><topic>Patients</topic><topic>Prognosis</topic><topic>prognostic factors</topic><topic>Proportional Hazards Models</topic><topic>Radiomics</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Statistical analysis</topic><topic>Survival analysis</topic><topic>Tomography, X-Ray Computed</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhu, Chao</creatorcontrib><creatorcontrib>Ding, Jialin</creatorcontrib><creatorcontrib>Wang, Songping</creatorcontrib><creatorcontrib>Qiu, Qingtao</creatorcontrib><creatorcontrib>Ji, Youxin</creatorcontrib><creatorcontrib>Wang, Linlin</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley Online Library Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Thoracic cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhu, Chao</au><au>Ding, Jialin</au><au>Wang, Songping</au><au>Qiu, Qingtao</au><au>Ji, Youxin</au><au>Wang, Linlin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors</atitle><jtitle>Thoracic cancer</jtitle><addtitle>Thorac Cancer</addtitle><date>2021-12</date><risdate>2021</risdate><volume>12</volume><issue>23</issue><spage>3110</spage><epage>3120</epage><pages>3110-3120</pages><issn>1759-7706</issn><eissn>1759-7714</eissn><abstract>Background
The current study aimed to comprehensively analyze the clinical prognostic factors of malignant esophageal fistula (MEF). Furthermore, this study sought to establish and validate prognostic nomograms incorporating radiomics and clinical factors to predict overall survival and median survival after fistula for patients with MEF.
Methods
The records of 76 patients with MEF were retrospectively analyzed. A stepwise Cox proportional hazards regression model was employed to screen independent prognostic factors and develop clinical nomograms. Radiomic features were extracted from prefistula CT images and post fistula CT images. Least absolute shrinkage and selection operator (LASSO) regression and Cox regression algorithm was used to filter radiomic features and avoid overfitting. Radiomic signature was a linear combination of optimal features and corresponding coefficients. The joint prognostic nomograms was constructed by radiomic signatures and clinical features. All models were validated by Harrell's concordance index (C‐index), caliberation and bootstrap validation.
Results
For overall survival, age, prealbumin, KPS and interval between diagnosis of esophageal cancer and fistula were identified as independent prognostic factors and incorporated into the clinical nomogram. Age, prealbumin, serum albumin, KPS and neutrophil proportion were selected for the clinical nomogram of post fistula survival. The C‐index of overall survival nomogram was 0.719 (95% CI: 0.645–0.793) and that was 0.722 (95% CI: 0.653–0.791) in the post fistula survival nomogram. The radiomic signature developed by radiomic features of prefistula CT showed a significant correlation with both overall survival and post fistula survival. The C‐index of joint nomogarm for overall survival and post fistula survival was 0.831 (95% CI: 0.757–0.905) and 0.77 (95% CI: 0.686–0.854), respectively. The calibration curve showed the joint nomograms outperformed the clinical ones.
Conclusions
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of MEF. This prognostic classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistulas.
The study presents nomograms incorporating independent clinical risk factors and radiomic signature to predict the prognosis of malignant esophageal fistula. This risk classification system has the potential to guide therapeutic decisions for patients with malignant esophageal fistula.</abstract><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>34647417</pmid><doi>10.1111/1759-7714.14115</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7879-7281</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1759-7706 |
ispartof | Thoracic cancer, 2021-12, Vol.12 (23), p.3110-3120 |
issn | 1759-7706 1759-7714 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d55ac551265e49c2a72b7580f2061d4d |
source | Open Access: Wiley-Blackwell Open Access Journals; Publicly Available Content Database; PubMed Central |
subjects | Aged Body mass index Cancer therapies Chemotherapy Disease-Free Survival Esophageal cancer esophageal fistula Esophageal Fistula - diagnostic imaging Esophageal Fistula - pathology Esophageal Neoplasms - diagnostic imaging Esophageal Neoplasms - pathology Female Fistula Humans Male Medical prognosis Medical records Middle Aged Neutrophils Nomograms Open source software Original Patients Prognosis prognostic factors Proportional Hazards Models Radiomics Retrospective Studies Risk Factors Statistical analysis Survival analysis Tomography, X-Ray Computed Tumors |
title | Development and validation of a prognostic nomogram for malignant esophageal fistula based on radiomics and clinical factors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T19%3A18%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20and%20validation%20of%20a%20prognostic%20nomogram%20for%20malignant%20esophageal%20fistula%20based%20on%20radiomics%20and%20clinical%20factors&rft.jtitle=Thoracic%20cancer&rft.au=Zhu,%20Chao&rft.date=2021-12&rft.volume=12&rft.issue=23&rft.spage=3110&rft.epage=3120&rft.pages=3110-3120&rft.issn=1759-7706&rft.eissn=1759-7714&rft_id=info:doi/10.1111/1759-7714.14115&rft_dat=%3Cproquest_doaj_%3E2604953177%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5335-504bb8653da5bf5d817b4706f081b91d396818e87ca7ad4bfb018e1d0f29e6d73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2604953177&rft_id=info:pmid/34647417&rfr_iscdi=true |